Shared Instrumentation Grant Program

by: Iola Bonggay

The National Institutes of Health, otherwise known as NIH, is an independent agency operating within the United States Department of Health and Human services that is primarily responsible for pursuing most of the country's biomedical and health-related research studies.

The mission of the NIH has always been to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In an effort to contribute to the realization of this mission, the National Institutes of Health has recently established the Shared Instrumentation Grant Program wherein they intend to solicit applications from NIH-supported research proposing to upgrade or purchase a single piece of expensive instrumentation (useful to the field of science and technology) that at a minimum costs $100,000.

Initially, this program seeks to support the National Center for Research Resources(NCRR) Shared Instrumentation Grant(SIG) Program. The project looks to provide funds to enable NIH-recognized institutions to purchase rather expensive research instruments that can only be justified on a shared-use basis and that are needed for NIH-supported projects in translational, basic, or clinical areas.

  (continued...)

Shared Instrumentation Grant Program
  Page 2

About The Author Iola Bonggay is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. She also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---

Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program
In keeping with this mission, the National Institutes of Health has partnered with the Canadian Institutes of Health Research (CIHR), the National Heart, Lung, and Blood Institute (NHLBI), and the Institute of Circulatory and Respiratory Health (ICRH) to establish the Core Clinical Centers for the Cardiothoracic Surgical Trials Network Program.

---

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Critical Congenital Heart Disease Newborn Screening Demonstration Program
The Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

---